ストックスクリーナーアプリを入手
6.98
0.94%
0.065
アフターアワーズ：
6.80
-0.18
-2.58%
前日終値:
$6.915
開ける：
$6.7501
24時間の取引高:
2,482
Relative Volume:
0.24
時価総額：
$19.64M
収益：
$20.92M
当期純損益:
$-25.87M
株価収益率:
-0.3546
EPS:
-19.6815
ネットキャッシュフロー:
$-15.02M
1週間 パフォーマンス:
-1.27%
1か月 パフォーマンス:
+4.18%
6か月 パフォーマンス:
-9.17%
1年 パフォーマンス:
-47.12%
1日の値動き範囲:
$6.7501
$6.98
1週間の範囲:
$6.20
$7.10
52週間の値動き範囲:
$4.14
$13.20
Lifeward Ltd Stock (LFWD) Company Profile
Compare LFWD vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LFWD
Lifeward Ltd
|
6.98 | 19.57M | 20.92M | -25.87M | -15.02M | -19.68 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-10 | 開始されました | Laidlaw | Buy |
| 2017-04-03 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2016-12-16 | 開始されました | Oppenheimer | Outperform |
| 2016-07-15 | 開始されました | Piper Jaffray | Overweight |
| 2015-05-22 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2015-05-08 | 繰り返されました | Barclays | Equal Weight |
| 2014-10-07 | 開始されました | Barclays | Equal Weight |
すべてを表示
Lifeward Ltd (LFWD) 最新ニュース
Lifeward Ltd. (LFWD) Q1 2026 Earnings: Deep EPS Miss Tempered by Resilient Stock PerformanceProfit Warning Alert - newsline.com
LFWD Q1 2026 Earnings: Significant EPS Miss Amidst Unreported RevenueROIC Trend Report - newsline.com
Lifeward Ltd. (LFWD) Hovers Near Support as Minimal Downside Move Signals CautionLarge Cap Trends - newsline.com
Lifeward Ltd. (LFWD) Holds Steady Near Support Amid Quiet Trading SessionSector Leader Stocks - newsline.com
LFWD Q1 2026 Earnings: Significant EPS Miss Weighs on StockEPS Consistency Score - newsline.com
LFWD Q1 2026 Earnings: Significant EPS Miss Amid Challenging QuarterGuidance vs Actual - newsline.com
LFWD Technical Analysis | Trend, Signals & Chart Patterns | LIFEWARD LTD (NASDAQ:LFWD) - ChartMill
LFWD News | LIFEWARD LTD (NASDAQ:LFWD) - ChartMill
LFWD Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Revenue Not DisclosedEPS Revision Trend - newsline.com
Lifeward Q1 2026 Earnings: Significant EPS Miss Reflects Continued InvestmentEarnings Cycle Report - The Legal Advocate
LFWD Q1 2026 Earnings: EPS Misses Estimates by Wide Margin as Company Faces ChallengesMid-Term Outlook - newsline.com
Why Is Lifeward Ltd. (LFWD) Stock Down Today? - Meyka
Lifeward Ltd. (LFWD) Edges Higher as Support Holds, Resistance in FocusParabolic SAR - The Legal Advocate
Lifeward Ltd. (LFWD) Gains Ground: Testing Key Resistance at $7.48Death Cross - newsline.com
LFWD Q1 2026 Earnings: Significant EPS Miss Despite Stock RallyLow Growth Earnings - newsline.com
H.C. Wainwright Maintains Lifeward(LFWD.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Lifeward Ltd. (LFWD) Nears Key Support Amid Modest DeclineSupport Level Bounce - newsline.com
Lifeward Ltd. (LFWD) Surges Over 11% as Shares Test Key ResistanceVolatility Stop - The Legal Advocate
Lifeward (LFWD) Q4 2025 Earnings Transcript - AOL.com
Lifeward’s Earnings Call Balances Setbacks and Strategy - The Globe and Mail
Lifeward (Nasdaq: LFWD) posts wider Q1 loss, adds Oratech and new convertible debt - Stock Titan
Lifeward (LFWD) Chief Medical Officer receives 15,000-share RSU award - Stock Titan
Lifeward (LFWD) Chief Medical Officer discloses 2,083 ordinary shares - Stock Titan
Lifeward promotes Keith Rose to chief medical officer By Investing.com - Investing.com Nigeria
Lifeward Ltd. Appoints Keith D. Rose, M.D. as Chief Medical Officer – SEC 8-K Filing May 2026 - Minichart
Lifeward appoints Keith D. Rose, M.D. as chief medical officer By Investing.com - Investing.com Australia
Lifeward appoints Keith D. Rose, M.D. as chief medical officer - Investing.com
Lifeward Names Keith D. Rose as Chief Medical Officer - TipRanks
Lifeward (NASDAQ: LFWD) appoints Keith D. Rose, M.D. as new CMO - Stock Titan
Lifeward promotes Keith Rose to chief medical officer - Investing.com
Lifeward Appoints Dr. Keith D. Rose as Chief Medical - GlobeNewswire
Lifeward Ltd.16079622026 - SEC.gov
Lifeward (LFWD) price target decreased by 37.93% to 4.59 - MSN
How The Lifeward (LFWD) Story Is Shifting With New Price Targets And Valuation Assumptions - Yahoo Finance
Lifeward Ltd (LFWD) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing Growth Opportunities - GuruFocus
Lifeward Earnings Call Balances Growth With Disruptions - The Globe and Mail
Number of shareholders of Lifeward Ltd. – BOATS:LFWD - TradingView
Lifeward Q1 earnings preview - MSN
Earnings Call Summary | Lifeward(LFWD.US) Q1 2026 Earnings Conference - 富途牛牛
Lifeward 1Q Loss/Shr $6.70 >LFWD - Moomoo
Lifeward Q1 2026 Loss Deepens: -$3.13/Share vs -$0.34 Expected - AlphaStreet
Lifeward Ltd (LFWD) Q1 2026 Earnings Miss: EPS -$6.70 vs -$1.26 - GuruFocus
Lifeward (LFWD) Q1 2026 Earnings Transcript - AOL.com
Lifeward expects 2026 revenue similar to 2025 following Oratech acquisition and $10M convertible note financing - MSN
Lifeward Ltd. Q1 2026 Earnings Call Summary - Yahoo Finance
Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates - sharewise.com
Lifeward Ltd. Closes Oratech Acquisition, Receives $10M Financing, Launches Phase 2 Oral Insulin Trial, and Expands Exoskeleton Technology for Stroke Rehabilitation - Minichart
Transcript : Lifeward Ltd., Q1 2026 Earnings Call, May 15, 2026 - marketscreener.com
Lifeward Ltd (NASDAQ:LFWD) Q1 Revenue Misses Estimates as Strategic Transformation Takes Shape - ChartMill
Lifeward Delays Quarterly Report Amid Deal Accounting - TipRanks
Lifeward Ltd (LFWD) 財務データ
収益
当期純利益
現金流量
EPS
2.43%
大文字化:
|
ボリューム (24 時間):